Understanding Biogen’s Unusual Options Activity
On Friday, shares of Biogen (NASDAQ:BIIB) saw unusual options activity. After the option alert, the stock price moved up to $369.73.
Cassava Sciences Shares Fall Sharply Lower After STAT News Reports ‘FDA calls for federal investigation into its controversial Alzheimer’s drug approval’
https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/
‘FDA calls for federal investigation into its controversial Alzheimer’s drug approval’ -STAT News Report
https://www.statnews.com/2021/07/09/fda-investigation-alzheimers-drug-approval/
Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp (NASDAQ: AVXL) because Biogen Inc (NASDAQ:
AbbVie, Biogen, Pfizer Report Collaboration To Create World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Today, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie
Baidu And Nvidia Lead The QQQ Lower Thursday
U.S. indices were trading lower Thursday amid concerns the economic recovery is slowing. Growing concerns over the COVID-19 Delta variant have also weighed on sentiment amid a rise in cases in some U.S. states and a state of emergency declared in Japan.
FDA Narrows Label To Recommend Use Of Biogen’s Aduhelm In Mild Alzheimer’s Patients
Biogen Inc. (NASDAQ: BIIB) shares are lower after the company announced an updated label for its recently-approved Alzheimer's treatment Adu
Biogen Announces FDA Approval Of Updated ADUHELM Prescribing Information
Biogen (NASDAQ:BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced the U.S. Food and Drug Administration (FDA) has approved an updated label for ADUHELM™ (aducanumab-avwa) injection 100 mg/mL
Oracle And CarMax Lead The SPY Higher Wednesday
U.S. indices were trading higher Wednesday after the 10-year treasury yield fell to its lowest level since February at 1.3%.